BeOne Medicines (BEIGF) Current Taxes (2016 - 2026)

BeOne Medicines (BEIGF) has reported Current Taxes for 11 consecutive years, with $76.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Taxes rose 1278.52% year-over-year to $76.3 million in Q2 2026; TTM through Jun 2026 was $76.3 million, a 1278.52% increase from a year earlier, with the FY2025 full-year figure at $41.6 million, up 60.53% from the prior year.
• Current Taxes was $76.3 million for Q2 2026 at BeOne Medicines, up from $63.5 million in the prior quarter.
• Over five years, Current Taxes peaked at $76.3 million in Q2 2026 and troughed at $5.3 million in Q2 2024.
• A 5-year average of $27.9 million and a median of $24.1 million in 2022 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes slumped 69.09% in 2024 and soared 1278.52% in 2026, its largest moves.
• Over 5 years, Current Taxes stood at $25.2 million in 2022, then fell by 8.88% to $23.0 million in 2023, then increased by 12.98% to $25.9 million in 2024, then jumped by 60.53% to $41.6 million in 2025, then soared by 83.34% to $76.3 million in 2026.
• The last three Current Taxes figures came in at $76.3 million (Q2 2026), $63.5 million (Q1 2026), and $41.6 million (Q4 2025), per Business Quant data.